Skip to content

NAMS

NewAmsterdam Pharma Co. NV

NASDAQ · Healthcare · Biotechnology · NL

$22.49
+2.55%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward
97.98x

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
4.26x
Price / sales
377.53x
Price / cash flow
-18.74x

Enterprise value

Enterprise value
$2.1B
EV / sales
288.53x
EV / EBITDA
-8.06x
EV / EBIT
-8.41x
Market cap
$2.7B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026